RecruitingPhase 1NCT06884059

Time Restricted Eating in Patients With Microalbuminuria

Impact of Time-Restricted Eating (TRE) on Kidney Health (The TREK Study)

Sponsor

University of California, San Diego

Enrollment

25 participants

Start Date

Jul 1, 2026

Study Type

INTERVENTIONAL

Conditions

Type 2 Diabetes Mellitus (T2DM)Time Restricted Eating Microalbuminuria

Summary

This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Time Restricted Eating for people with microalbuminuria, time restricted eating, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTime Restricted Eating

Participants in the TRE group with continue to follow their physicians treatment plan for type II diabetes mellitus and consume all of their food within an 8-10 hour eating window.

Locations(1)

Altman Clinical and Translational Research Institute

La Jolla, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06884059

Related Trials

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

NCT074652241 location

Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

NCT077198941 location

A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes

NCT0767041612 locations

The GRoceries Aimed at Increasing Nutrition Study

NCT071670041 location

Salivary Apelin, Chemerin, Ghrelin, and Lipocalin-2 Levels in Diabetic Patients With Periodontitis

NCT077033451 location